(Q36482539)

14 August 2017

CD44 Variant 9 Serves as a Poor Prognostic Marker in Early Gastric Cancer, But Not in Advanced Gastric Cancer (English)

1 reference

14 August 2017

Se-Il Go

1

1 reference

14 August 2017

Gyung Hyuck Ko

2

1 reference

14 August 2017

Won Sup Lee

3

1 reference

14 August 2017

Rock Bum Kim

4

1 reference

14 August 2017

Jeong-Hee Lee

5

1 reference

14 August 2017

Sang-Ho Jeong

6

1 reference

14 August 2017

Young-Joon Lee

7

1 reference

14 August 2017

Soon Chan Hong

8

1 reference

14 August 2017

Woo Song Ha

9

1 reference

14 August 2017

17 March 2015

1 reference

Cancer Research and Treatment

14 August 2017

1 reference

14 August 2017

48

1 reference

14 August 2017

1

1 reference

14 August 2017

142-152

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

14 August 2017

start time

17 March 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2011.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4720095

CD44 variant 9 expression in primary early gastric cancer as a predictive marker for recurrence.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4720095

CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4720095

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4720095

Phenotypic characterization of human colorectal cancer stem cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4720095

Molecular genetic characterization of alternatively spliced CD44 transcripts in human stomach carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4720095

A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4720095

The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4720095

CD44 is the principal cell surface receptor for hyaluronate

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4720095

CD44H regulates tumor cell migration on hyaluronate-coated substrate

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4720095

CD44+ slow-cycling tumor cell expansion is triggered by cooperative actions of Wnt and prostaglandin E2 in gastric tumorigenesis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4720095

Increased expression of CD44v6 mRNA significantly correlates with distant metastasis and poor prognosis in gastric cancer

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4720095

Expression and prognostic value of the CD44 splicing variants v5 and v6 in gastric cancer

28 June 2018

1 reference

12 December 2020

Expression of CD44v6 in advanced gastric cancer and its relationship to hematogenous metastasis and long-term prognosis

1 reference

12 December 2020

Expression of a CD44 variant containing exons 8 to 10 is a useful independent factor for the prediction of prognosis in colorectal cancer patients

1 reference

12 December 2020

Expression of CD44 containing variant exon 9 (CD44v9) in gastric adenomas and adenocarcinomas: relation to the proliferation and progression

1 reference

12 December 2020

Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins

1 reference

12 December 2020

Identifiers

DOI

10.4143/CRT.2014.227

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

25779358

1 reference